Verition Fund Management
NVO

Verition Fund Management’s Novo Nordisk NVO Stock Holding History

Verition Fund Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-36,435
Closed -$2.02M – 3813
2025
Q3 		$2.02M Buy
36,435
+7,507
+26% +$439K 0.01% 1970
2025
Q2 		$2M Sell
28,928
-13,521
-32% -$920K 0.01% 1948
2025
Q1 		$2.95M Buy
42,449
+36,830
+655% +$3.04M 0.01% 1280
2024
Q4 		$483K Sell
5,619
-45,603
-89% -$4.93M ﹤0.01% 2506
2024
Q3 		$6.1M Buy
51,222
+49,720
+3,310% +$6.63M 0.03% 721
2024
Q2 		$214K Sell
1,502
-243
-14% -$32.2K ﹤0.01% 2551
2024
Q1 		$224K Sell
1,745
-1,001
-36% -$119K ﹤0.01% 2445
2023
Q4 		$284K Buy
+2,746
New +$272K ﹤0.01% 1832
2020
Q1 		– Sell
-25,212
Closed -$730K – 920
2019
Q4 		$730K Buy
+25,212
New +$698K 0.01% 540
2018
Q4 		– Sell
-72,784
Closed -$1.72M – 1119
2018
Q3 		$1.72M Buy
72,784
+59,916
+466% +$1.46M 0.06% 356
2018
Q2 		$297K Buy
12,868
+4,042
+46% +$96.1K 0.02% 863
2018
Q1 		$217K Buy
+8,826
New +$232K 0.02% 972
2017
Q4 		– Sell
-9,732
Closed -$234K – 1125
2017
Q3 		$234K Sell
9,732
-21,500
-69% -$486K 0.02% 996
2017
Q2 		$670K Buy
+31,232
New +$630K 0.07% 314
2017
Q1 		– Sell
-36,370
Closed -$652K – 1373
2016
Q4 		$652K Sell
36,370
-34,926
-49% -$633K 0.06% 423
2016
Q3 		$1.48M Buy
71,296
+62,124
+677% +$1.54M 0.16% 133
2016
Q2 		$247K Buy
+9,172
New +$252K 0.03% 674

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verition Fund Management's NVO Position: Q4 2025 in Review

Verition Fund Management sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 36,435 shares — an estimated $2.02M sold.

Verition Fund Management first reported a position in NVO in Q2 2016 and held it in 17 quarters. The position peaked at $6.1M in Q3 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Verition Fund Management reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 36,435 Novo Nordisk shares in Q4 2025, an estimated $2.02M.
  • Verition Fund Management first reported a position in Novo Nordisk in Q2 2016 and held it in 17 quarters.
  • Verition Fund Management's Novo Nordisk position peaked at $6.1M in Q3 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.